Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs771476 | chr1:93851864 | C/T | 3.56E-6 | 494 | 31.3 | 28.67 | 18.97 | KM Plot |
| PRAD | rs771479 | chr1:93848560 | C/A | 3.54E-6 | 494 | 31.37 | 28.13 | 18.97 | KM Plot |
| PRAD | rs771482 | chr1:93844057 | G/A | 3.59E-6 | 494 | 31.33 | 28.4 | 18.97 | KM Plot |
| PRAD | rs77175292 | chr5:154161173 | A/C | 0 | 491 | 29.97 | 35.57 | 4.87 | KM Plot |
| PRAD | rs77177161 | chr11:6923149 | C/G | 1.53E-12 | 484 | 30.8 | 29.97 | 18.13 | KM Plot |
| PRAD | rs77180878 | chr2:241753651 | A/C | 1.62E-6 | 488 | 29.32 | 33.02 | 26.78 | KM Plot |
| PRAD | rs7720150 | chr5:138334069 | C/A | 9.67E-5 | 492 | 32.77 | 30.57 | 28.73 | KM Plot |
| PRAD | rs77237902 | chr5:154339093 | G/A | 0 | 489 | 30.3 | 32.85 | 4.87 | KM Plot |
| PRAD | rs77241311 | chr6:43364043 | C/T | 4.11E-12 | 485 | 31.27 | 29.4 | 44.3 | KM Plot |
| PRAD | rs77241855 | chr4:165645314 | TA/T | 5.68E-5 | 492 | 30.77 | 32.9 | 44.32 | KM Plot |
| PRAD | rs77254963 | chr11:1653954 | A/G | 7.66E-5 | 489 | 28.8 | 29.2 | 31.63 | KM Plot |
| PRAD | rs77263000 | chr7:135099419 | C/T | 2.09E-9 | 491 | 30.8 | 31.33 | 3.03 | KM Plot |
| PRAD | rs7727405 | chr5:171738710 | C/T | 1.22E-5 | 494 | 30.77 | 33.07 | 28.43 | KM Plot |
| PRAD | rs77288214 | chr11:24224014 | T/G | 5.74E-9 | 493 | 30.8 | 38.65 | 22.92 | KM Plot |
| PRAD | rs77348459 | chr1:3225368 | G/T | 8.86E-10 | 488 | 30.78 | 31.4 | 15.17 | KM Plot |